©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2014; 20(3): 814-821
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.814
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.814
Table 5 Type of treatment, relapses, histopathological and laboratory findings of ulcerative colitis patients
| Treatment used: (single drug or combinations) Oral 5-ASA ±, 5-ASAenemas or supp., prednisone, azathioprine, corticosteroids enemas. (Infliximab was used in 2 cases) | |
| Surgical interference (yes/no) | 4/131 |
| Relapses (mean ± SD) | 1.514 ± 1.575 |
| Relapses (median/minimum/maximum) | 1/0/10 |
| Malignant transformation | 1 |
| Mean ESR 1st hour (mean ± SD) | 36.37 ± 24.73 |
| CRP (positive/negative/not done) | 39/34/60 |
| ANCA (positive/negative/not done) | 12/28/95 |
| ASCA (positive/negative/not done) | 8/31/96 |
| Pathological findings included: Vascular congestion, Crypt abscesses, Mucin depletion, Cellular infiltrate, Cryptitis, Crypt branching | |
| Pathology (diagnostic/suggestive/non conclusive) | 78/43/14 |
| Mean Hemoglobin concentration, gm/dL (mean ± SD) | 11.2 ± 2.8 |
| Mean PLT count (mean ± SD) | 335428.6 ± 140119.1 |
| Mean TLC (mean ± SD) | 8875 ± 4059.67 |
- Citation: Esmat S, El Nady M, Elfekki M, Elsherif Y, Naga M. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt. World J Gastroenterol 2014; 20(3): 814-821
- URL: https://www.wjgnet.com/1007-9327/full/v20/i3/814.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i3.814